{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T04:02:18Z","timestamp":1772769738315,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17H01424"],"award-info":[{"award-number":["17H01424"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17H06416"],"award-info":[{"award-number":["17H06416"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.bbrc.2019.04.115","type":"journal-article","created":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T08:43:12Z","timestamp":1556095392000},"page":"217-223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Calnexin promotes the folding of mutant iduronate 2-sulfatase related to mucopolysaccharidosis type II"],"prefix":"10.1016","volume":"514","author":[{"given":"Yosuke","family":"Osaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Matsuhisa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang","family":"Che","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0477-0171","authenticated-orcid":false,"given":"Masayuki","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"Asada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Masaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Imaizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2019.04.115_bib1","first-page":"329","article-title":"The mucopolysaccharidoses","volume":"23","author":"Wraith","year":"1987","journal-title":"Aust. Paediatr. J."},{"key":"10.1016\/j.bbrc.2019.04.115_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ymgme.2018.01.003","article-title":"Clinical presentation and diagnosis of mucopolysaccharidoses","volume":"125","author":"Stapleton","year":"2018","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.bbrc.2019.04.115_bib3","doi-asserted-by":"crossref","first-page":"8531","DOI":"10.1073\/pnas.87.21.8531","article-title":"Hunter syndrome: isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA","volume":"87","author":"Wilson","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2019.04.115_bib4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/ajmg.a.38551","article-title":"Intrafamilial variability in the clinical manifestations of mucopolysaccharidosis type II: data from the Hunter Outcome Survey (HOS)","volume":"176","author":"Ficicioglu","year":"2018","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.bbrc.2019.04.115_bib5","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s10545-006-0440-7","article-title":"Effect of Hunter disease (mucopolysaccharidosis type II) mutations on molecular phenotypes of iduronate-2-sulfatase: enzymatic activity, protein processing and structural analysis","volume":"29","author":"Sukegawa-Hayasaka","year":"2006","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.bbrc.2019.04.115_bib6","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ymgme.2018.04.013","article-title":"Efficacy of Idursulfase therapy in patients with Mucopolysaccharidosis type II who initiated enzyme replacement therapy in adult age. A systematic review of the literature","volume":"124","author":"P\u00e9rez-L\u00f3pez","year":"2018","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.bbrc.2019.04.115_bib7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/GIM.0b013e3181fea459","article-title":"Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome","volume":"13","author":"Muenzer","year":"2011","journal-title":"Genet. Med."},{"key":"10.1016\/j.bbrc.2019.04.115_bib8","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/gim.2017.30","article-title":"Treatment of mucopolysaccharidosis type II (Hunter syndrome): results from a systematic evidence review","volume":"19","author":"Bradley","year":"2017","journal-title":"Genet. Med."},{"key":"10.1016\/j.bbrc.2019.04.115_bib9","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.bbmt.2017.06.020","article-title":"Hematopoietic stem cell transplantation for patients with mucopolysaccharidosis II","volume":"23","author":"Kubaski","year":"2017","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.bbrc.2019.04.115_bib10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S2352-4642(17)30087-1","article-title":"Neurological manifestations of lysosomal disorders and emerging therapies targeting the CNS","volume":"2","author":"Giugliani","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.bbrc.2019.04.115_bib11","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s10545-018-0221-0","article-title":"The efficacy of intracerebroventricular idursulfase-beta enzyme replacement therapy in mucopolysaccharidosis II murine model: heparan sulfate in cerebrospinal fluid as a clinical biomarker of neuropathology","volume":"41","author":"Sohn","year":"2018","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.bbrc.2019.04.115_bib12","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.86696","article-title":"CNS-directed gene therapy for the treatment of neurologic and somatic mucopolysaccharidosis type II (Hunter syndrome)","volume":"1","author":"Motas","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbrc.2019.04.115_bib13","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.ymthe.2018.02.032","article-title":"A\u00a0blood-brain-barrier-penetrating anti-human transferrin receptor antibody fusion protein for neuronopathic mucopolysaccharidosis II","volume":"26","author":"Sonoda","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbrc.2019.04.115_bib14","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ymthe.2018.12.005","article-title":"Iduronate-2-Sulfatase with anti-human transferrin receptor antibody for neuropathic mucopolysaccharidosis II: a phase 1\/2 trial","volume":"27","author":"Okuyama","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbrc.2019.04.115_bib15","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1089\/hum.2016.184","article-title":"Prevention of neurocognitive deficiency in mucopolysaccharidosis type II mice by central nervous system-directed, AAV9-mediated iduronate sulfatase gene transfer","volume":"28","author":"Laoharawee","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.bbrc.2019.04.115_bib16","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00439-004-1234-3","article-title":"Expression studies of mutations underlying Taiwanese Hunter syndrome (mucopolysaccharidosis type II)","volume":"116","author":"Chang","year":"2005","journal-title":"Hum. Genet."},{"key":"10.1016\/j.bbrc.2019.04.115_bib17","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/s41419-018-0871-8","article-title":"Shutdown of ER-associated degradation pathway rescues functions of mutant iduronate 2-sulfatase linked to mucopolysaccharidosis type II","volume":"9","author":"Osaki","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2019.04.115_bib18","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/tra.12358","article-title":"N-Glycan-based ER molecular chaperone and protein quality control system: the calnexin binding cycle","volume":"17","author":"Lamriben","year":"2016","journal-title":"Traffic"},{"key":"10.1016\/j.bbrc.2019.04.115_bib19","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1042\/EBC20160003","article-title":"Protein quality control at the endoplasmic reticulum","volume":"60","author":"McCaffrey","year":"2016","journal-title":"Essays Biochem."},{"key":"10.1016\/j.bbrc.2019.04.115_bib20","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.semcdb.2010.03.006","article-title":"Protein quality control in the ER: the recognition of misfolded proteins","volume":"21","author":"M\u00e4\u00e4tt\u00e4nen","year":"2010","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.bbrc.2019.04.115_bib21","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1126\/science.1209235","article-title":"Road to ruin: targeting proteins for degradation in the endoplasmic reticulum","volume":"334","author":"Smith","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2019.04.115_bib22","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a033928","article-title":"Chaperoning endoplasmic reticulum-associated degradation (ERAD) and protein conformational diseases","author":"Needham","year":"2019","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.bbrc.2019.04.115_bib23","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1074\/jbc.RA117.001159","article-title":"Endoplasmic reticulum-retained podocin mutants are massively degraded by the proteasome","volume":"293","author":"Serrano-Perez","year":"2018","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2019.04.115_bib24","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.chembiol.2014.06.008","article-title":"ERdj3 is an endoplasmic reticulum degradation factor for mutant glucocerebrosidase variants linked to Gaucher's disease","volume":"21","author":"Tan","year":"2014","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bbrc.2019.04.115_bib25","doi-asserted-by":"crossref","first-page":"31517","DOI":"10.1074\/jbc.M113.476010","article-title":"The unfolded protein response transducer ATF6 represents a novel transmembrane-type endoplasmic reticulum-associated degradation substrate requiring both mannose trimming and SEL1L protein","volume":"288","author":"Horimoto","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2019.04.115_bib26","doi-asserted-by":"crossref","first-page":"6992","DOI":"10.1038\/srep06992","article-title":"Rer1 and calnexin regulate endoplasmic reticulum retention of a peripheral myelin protein 22 mutant that causes type 1A Charcot-Marie-Tooth disease","volume":"4","author":"Hara","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2019.04.115_bib27","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.bbamcr.2008.04.002","article-title":"Role of calnexin in the ER quality control and productive folding of CFTR; differential effect of calnexin knockout on wild-type and DeltaF508 CFTR","volume":"1783","author":"Okiyoneda","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2019.04.115_bib28","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1242\/jcs.028951","article-title":"Role of N-linked oligosaccharides in the biosynthetic processing of the cystic fibrosis membrane conductance regulator","volume":"121","author":"Chang","year":"2008","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.bbrc.2019.04.115_bib29","doi-asserted-by":"crossref","first-page":"15786","DOI":"10.1038\/ncomms15786","article-title":"Insights into Hunter syndrome from the structure of iduronate-2-sulfatase","volume":"8","author":"Demydchuk","year":"2017","journal-title":"Nat. Commun."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X19307594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X19307594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T17:20:06Z","timestamp":1770830406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X19307594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0006291X19307594"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2019.04.115","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Calnexin promotes the folding of mutant iduronate 2-sulfatase related to mucopolysaccharidosis type II","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2019.04.115","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}